Ocugen, Inc. (OCGN)
1.965
+0.10
(+5.65%)
USD |
NASDAQ |
Mar 04, 16:00
1.95
-0.02
(-0.76%)
After-Hours: 18:44
Ocugen Research and Development Expense (Annual) : 30.16M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| MannKind Corp. | 66.35M |
| CorMedix, Inc. | 3.942M |
| Alector, Inc. | 113.40M |
| Phathom Pharmaceuticals, Inc. | 32.78M |
| Keros Therapeutics, Inc. | 173.63M |